907 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by Brucke Financial Inc.

Brucke Financial Inc. acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, Holdings Channel reports. The institutional investor acquired 907 shares of the healthcare conglomerate’s stock, valued at approximately $492,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. Western Pacific Wealth Management LP boosted its holdings in UnitedHealth Group by 2.2% in the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock valued at $456,000 after purchasing an additional 19 shares during the last quarter. Axiom Financial Strategies LLC boosted its holdings in UnitedHealth Group by 3.6% in the fourth quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock valued at $291,000 after purchasing an additional 20 shares during the last quarter. Richwood Investment Advisors LLC boosted its holdings in UnitedHealth Group by 0.4% in the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock valued at $2,654,000 after purchasing an additional 20 shares during the last quarter. Prentice Wealth Management LLC boosted its holdings in UnitedHealth Group by 0.8% in the fourth quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate’s stock valued at $1,278,000 after purchasing an additional 21 shares during the last quarter. Finally, 44 Wealth Management LLC lifted its holdings in UnitedHealth Group by 1.6% during the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock worth $662,000 after buying an additional 21 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In related news, CFO John F. Rex bought 17,175 shares of the business’s stock in a transaction on Friday, May 16th. The shares were bought at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now directly owns 203,796 shares in the company, valued at approximately $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Stephen J. Hemsley bought 86,700 shares of the business’s stock in a transaction on Friday, May 16th. The shares were bought at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now owns 679,493 shares of the company’s stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders bought 109,408 shares of company stock valued at $31,607,768. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $295.37 on Monday. The stock has a market cap of $267.94 billion, a PE ratio of 19.06, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The business has a fifty day simple moving average of $452.40 and a 200-day simple moving average of $503.72. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period last year, the business earned $6.91 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Wall Street Analyst Weigh In

UNH has been the topic of several recent research reports. Mizuho cut their price target on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a report on Friday, May 16th. Bank of America downgraded UnitedHealth Group from a “buy” rating to a “neutral” rating and cut their price target for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. TD Cowen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target on the stock. in a report on Monday, May 19th. Robert W. Baird cut their price target on UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating on the stock in a report on Wednesday, May 14th. Finally, Argus downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $441.87.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.